Pharmaids Pharmaceuticals Ltd vs Sai Life Sciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 10, 2026

Key Highlights

The Latest Trading Price of Pharmaids Pharmaceuticals Ltd is ₹ 28.01 as of 10 Jun 15:30 . The P/E Ratio of Pharmaids Pharmaceuticals Ltd changed from 89.4 on March 2022 to 0 on March 2021 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Sai Life Sciences Ltd changed from 93.4 on March 2025 to 0 on March 2021 . This represents a CAGR of -100.00% over 2 years The Market Cap of Pharmaids Pharmaceuticals Ltd changed from ₹ 12.9 crore on March 2022 to ₹ 0 crore on March 2021 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Sai Life Sciences Ltd changed from ₹ 15883 crore on March 2025 to ₹ 0 crore on March 2021 . This represents a CAGR of -100.00% over 2 years The revenue of Pharmaids Pharmaceuticals Ltd for the Mar '26 is ₹ 7.28 crore as compare to the Dec '25 revenue of ₹ 5.51 crore. This represent the growth of 32.12% The revenue of Sai Life Sciences Ltd for the Mar '26 is ₹ 617.95 crore as compare to the Dec '25 revenue of ₹ 564.84 crore. This represent the growth of 9.4% The ebitda of Pharmaids Pharmaceuticals Ltd for the Mar '26 is ₹ -0.33 crore as compare to the Dec '25 ebitda of ₹ -2.83 crore. This represent the decline of -88.34% The ebitda of Sai Life Sciences Ltd for the Mar '26 is ₹ 192.36 crore as compare to the Dec '25 ebitda of ₹ 187.94 crore. This represent the growth of 2.35% The net profit of Pharmaids Pharmaceuticals Ltd changed from ₹ -3.12 crore to ₹ -1.08 crore over 8 quarters. This represents a CAGR of -41.17% The net profit of Sai Life Sciences Ltd changed from ₹ -13.5 crore to ₹ 104.24 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of Pharmaids Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sai Life Sciences Ltd changed from 443.82 % on March 2022 to 0 % on March 2025 . This represents a CAGR of -100.00% over 4 years .

About Pharmaids Pharmaceuticals Ltd

Pharmaids Pharmaceuticals Limited, incorporated in March, 1989 at Hyderabad, Telangana were suppliers of Quality Grade range of speciality chemicals, skin care, hospital care and generic products in the areas of Orthopedic, Neuro and Gastro etc.
The technical team used quality proven chemical compounds and standard processing methods maintaining proper hygiene standards.The Company is engaged in the business of contract research and manufacturing services. Emergent Bio Naturals Limited (EBNL) was amalgamated with the Company in 2019-20 and the Scheme of Amalgamation was effective on September 27, 2019.
Pursuant to the Scheme, 69,05,734 Equity Shares were allotted to Shareholders of Emergent Bio Naturals Limited on November 27, 2019. The Company acquired 25.5% stake as 1st tranche in Anugraha Chemicals, a Partnership Firm, registered under Karnataka Partnership Rules, 1954 on February 1, 2023.

About Sai Life Sciences Ltd

Sai Life Sciences Limited was originally incorporated as Sai Dru Syn Laboratories Limited' as a Public Limited Company, dated January 25, 1999, issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.
The Company received the Certificate of Commencement of Business from Registrar of Companies, Andhra Pradesh on February 17, 1999.
Subsequently, the Company name was changed from Sai Dru Syn Laboratories Limited' to Sai Life Sciences Limited' dated December 16, 2003. Thereafter, the name of the Company was changed from Sai Life Sciences Limited' to Sai Advantium Pharma Limited' dated August 30, 2006 issued by the Registrar of Companies, Andhra Pradesh.
Subsequently, the Company name was changed from Sai Advantium Pharma Limited' to Sai Life Sciences Limited' and a fresh Certificate of Incorporation dated May 28, 2012 was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.

FAQs for the comparison of Pharmaids Pharmaceuticals Ltd and Sai Life Sciences Ltd

Which company has a larger market capitalization, Pharmaids Pharmaceuticals Ltd or Sai Life Sciences Ltd?

Market cap of Pharmaids Pharmaceuticals Ltd is 98 Cr while Market cap of Sai Life Sciences Ltd is 25,217 Cr

What are the key factors driving the stock performance of Pharmaids Pharmaceuticals Ltd and Sai Life Sciences Ltd?

The stock performance of Pharmaids Pharmaceuticals Ltd and Sai Life Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Pharmaids Pharmaceuticals Ltd and Sai Life Sciences Ltd?

As of June 10, 2026, the Pharmaids Pharmaceuticals Ltd stock price is INR ₹28.01. On the other hand, Sai Life Sciences Ltd stock price is INR ₹1188.85.

How do dividend payouts of Pharmaids Pharmaceuticals Ltd and Sai Life Sciences Ltd compare?

To compare the dividend payouts of Pharmaids Pharmaceuticals Ltd and Sai Life Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.